Safety and Feasibility of Pediatric Home Blood Transfusion

Pediatric home blood transfusion is emerging as a critical component of palliative care for children with advanced-stage cancer. In Japan, researchers recently investigated the safety and feasibility of this practice. Between 2018 and 2024, the Tokiwa Group provided home-based palliative care to 39 pediatric patients. Among these, 16 children received a total of 281 transfusions, including both red blood cells and platelets. The study aimed to determine if such procedures could be conducted safely outside a hospital setting.

The retrospective analysis yielded promising results. Researchers found that transfusions performed at home were just as safe as those administered in a hospital. Specifically, the adverse event rate was only 2.1%. This low frequency of complications suggests that pediatric home blood transfusion is a viable option for children who are in the terminal stages of cancer. Furthermore, the ability to receive treatment at home significantly reduces the burden of frequent hospital visits for both the patient and their family.

Enhancing Quality of Life Through Home Care

Consequently, the increased use of home-based medical interventions could further enhance the quality of life for children with advanced malignancies. Since many pediatric patients with terminal cancer require regular supportive care, home-based services allow them to remain in a familiar and comfortable environment. Moreover, standardized protocols and mobile medical teams ensure that safety standards remain high. While the logistical framework for such services is still developing in many regions, the clinical data provides a strong foundation for expanding home-based transfusion programs.

Pediatric Home Blood Transfusion: Frequently Asked Questions

What are the most common adverse events in home transfusions?

Adverse events are rare, with studies reporting rates around 2.1%. The most common reactions include mild allergic responses, such as skin rashes or non-hemolytic febrile reactions. These are typically manageable at home with standard protocols.

Is home blood transfusion suitable for all pediatric cancer patients?

No, patient selection is vital. It is primarily intended for children with advanced-stage or terminal cancer receiving palliative care. Patients should have a stable history regarding previous transfusions and must be monitored by a specialized home care medical team.

How does home transfusion benefit the family?

It reduces the physical and emotional stress of transporting a frail child to the hospital. Additionally, it minimizes the disruption of daily life, allowing families to spend more quality time together in a domestic setting.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Sugiyama M et al. Feasibility and Safety of Home Blood Transfusion for Children With Advanced Stage Cancer: Experiences From a Single Institute. Pediatr Blood Cancer. 2026 Apr 02. doi: 10.1002/1545-5017.70306. PMID: 41924931.

Miyashita N et al. Effectiveness and Safety of Home-Based RBC Transfusions in Advanced Hematologic and Solid Tumors. J Pain Symptom Manage. 2026 Jan;71(1):110-118. doi: 10.1016/j.jpainsymman.2025.09.021.

De Zen L et al. Safety and Feasibility of Home Transfusions in Pediatric Palliative Care: A Preliminary Report. J Pain Symptom Manage. 2022 Feb;63(2):e246-e251. doi: 10.1016/j.jpainsymman.2021.09.018.